EUVIMEDEUVIMED entdecken
Open Access

Utility of Amniotic Fluid Biomarkers to Predict Preterm Delivery for Clinical Chorioamnionitis in Women With Intact Membranes

Harold Baxter iD, Ritu Mogra iD, Sarika Gupta, Adam Chan, Bradley de Vries iD, Rajit Narayan iD

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026-08 · 66 (4)

DOI: 10.1111/ajo.70168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 05.08.2026. Verfasst von Harold Baxter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Royal Prince Alfred Hospital, Women and Babies, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Chorioamnionitis, Amniotic Fluid, Premature Birth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sydney Local Health District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical chorioamnionitis is a major contributor to preterm birth and neonatal morbidity. Diagnosis in women with intact membranes is challenging, particularly in the subclinical phase where maternal signs are subtle and conventional serum markers are limited in predictive value.

Aims

To evaluate the diagnostic performance of selected novel amniotic fluid biomarkers (interleukin‐6, interleukin‐10, tumour necrosis factor‐ɑ, matrix metalloproteinase‐8), and conventional amniotic and serum biomarkers in predicting delivery for clinical chorioamnionitis within 14 days of amniocentesis in women with suspected subclinical infection and intact membranes. Materials and Methods A prospective cohort study was conducted at a single Australian tertiary hospital. Thirty‐two women with singleton pregnancies and suspected subclinical chorioamnionitis underwent amniocentesis. Amniotic fluid and serum were analysed for selected biomarkers. The primary outcome was delivery for clinical chorioamnionitis within 14 days of amniocentesis. ROC curves were constructed to assess biomarker performance.

Results

Delivery for clinical chorioamnionitis occurred in 11 of 31 evaluable cases (35%). Matrix metalloproteinase‐8, lactate dehydrogenase, and glucose were the strongest predictors (area under the curve (AUC) of 0.93 (95% CI 0.85–1.0), 0.93 (95% CI 0.85–1.0), and 0.92 (95% CI 0.8–1.0) respectively). Amniotic fluid biomarkers outperformed serum markers (C‐reactive protein AUC 0.70 (95% CI 0.49–0.91) and white cell count AUC 0.67 (95% CI 0.46–0.86)). Novel amniotic fluid biomarkers did not demonstrate superior diagnostic performance over conventional amniotic fluid biomarkers including lactate dehydrogenase and glucose.

Conclusions

Amniotic fluid biomarkers show promise in identifying women with subclinical chorioamnionitis. These findings support further validation of scalable biomarker‐based testing to guide early intervention and improve perinatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChorioamnionitisAmniotic FluidPremature BirthHumansFemalePregnancyBiomarkersProspective StudiesAmniocentesisMatrix Metalloproteinase 8AdultInterleukin-6Predictive Value of TestsTumor Necrosis Factor-alphaInterleukin-10ROC CurveL-Lactate Dehydrogenase

Stichwörter der Autor:innen

amniotic fluidbiomarkerschorioamnionitiscytokinespreterm birth

Substanzen

BiomarkersMatrix Metalloproteinase 8Interleukin-6Tumor Necrosis Factor-alphaInterleukin-10L-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Royal Prince Alfred Hospital, Women and Babies, Sydney, New South Wales, Australia.
  • Sydney Institute for Women, Children and their Families, Sydney Local Health District, Camperdown, New South Wales, Australia.
  • Department of Obstetrics and Gynaecology, Faculty of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.
  • Reproduction and Perinatal Centre, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Harold Baxter, Ritu Mogra, Bradley de Vries, Rajit Narayan

Förderung

  • Sydney Local Health District

Zitieren

APA

Baxter, H., Mogra, R., Gupta, S., Chan, A., de Vries, B., & Narayan, R. (2026). Utility of Amniotic Fluid Biomarkers to Predict Preterm Delivery for Clinical Chorioamnionitis in Women With Intact Membranes. Australian and New Zealand Journal of Obstetrics and Gynaecology, 66(4). https://doi.org/10.1111/ajo.70168

Vancouver

Baxter H, Mogra R, Gupta S, Chan A, de Vries B, Narayan R. Utility of Amniotic Fluid Biomarkers to Predict Preterm Delivery for Clinical Chorioamnionitis in Women With Intact Membranes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026;66(4). doi:10.1111/ajo.70168

BibTeX
@article{Baxter2026,
  author = {Baxter, Harold and Mogra, Ritu and Gupta, Sarika and Chan, Adam and de Vries, Bradley and Narayan, Rajit},
  title = {Utility of Amniotic Fluid Biomarkers to Predict Preterm Delivery for Clinical Chorioamnionitis in Women With Intact Membranes},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2026},
  volume = {66},
  number = {4},
  doi = {10.1111/ajo.70168}
}
Kostenlos starten →